Altimmune Stock

Altimmune P/B

The P/B (Price-to-Book Ratio) of Altimmune (ALT) as of Jul 23, 2026 is 4.44. In the previous year, P/B (Price-to-Book Ratio) was 2.83 — a change of 57.16% (higher).

P/B

4.44

YoY

57.16%

Last updated:

P/B (Price-to-Book Ratio) of Altimmune is 2026 4.44 . P/B (Price-to-Book Ratio) of Altimmune was 2025 2.83 . It decreases by 57.16% higher compared to the previous year.
Access this data via the Eulerpool API

Altimmune Stock analysis

What does Altimmune do? Altimmune Inc is a biopharmaceutical company specializing in the development of immunotherapies. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland, USA. Altimmune is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Altimmune stock

P/B (Price-to-Book Ratio) of Altimmune is 4.44 in 2026.

Access this data via the Eulerpool API

Valuation — Altimmune

All Key Metrics — Altimmune